Close

Analyst Ratings for Halozyme Therapeutics (HALO) [Neutrals]

HALO Rating Summary

HALO Price Target Summary

* Over Last 12-Mos
  |   Expand Research on HALO
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $49.13 (+23.3%) * Over Last 12-Mos
Rating Score: 7.1 / 10   Percentile Rank: 77%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/24/2023 Goldman Sachs
» Updated 1/18/2024
Corinne Jenkins Downgrade Neutral
(Buy)
40.00
(45.00)
42.57
(39.84)
-6.41% Details
3/16/2023 Leerink Partners David Risinger Downgrade Market Perform
(Outperform)
42.00
(N/A)
40.05
(39.84)
-0.52% Details
Like HALO Ratings? Also take a look at TAK

HALO Ratings News